Oura said more than half of its members identify as having obesity or being overweight, and tens of thousands already log GLP-1 therapy use in the app
High Bioverse ratings suggest good patient experience, but do not confirm clinical rigor, proper licensing, or personalization capability
Finally, there are mechanisms of action of these GLP-1s that we don't completely understand." The study is titled, "GLP1 Receptor Agonists and the Risk of Significant Hypotension Among Patients with Metabolic Cardiovascular Renal Disease: Too Much of A Good Thing?"
You plug a battery into the charger and suddenly get an error message
Regular use of Salicylic Acid products can help reduce the frequency of breakouts
Physician confidence is rising, and payer coverage is expanding as obesity therapies are increasingly treated as long-term metabolic treatments